PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.07

-0.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BigKNY3 who wrote (6982)	2/10/1999 7:26:00 PM
From: Anthony Wong	Read Replies (1) of 9523

Feb 10, 1999 (6:27 PM ET) - The Motley Fool Evening News Life sciences company Monsanto Co. (NYSE:MTC - news) gained $2 1/4 to $47 3/8 on news that its new anti-arthritis drug Celebrex is selling rapidly, generating 83,000 prescriptions in only its third week on the market. In comparison, Warner-Lambert's (NYSE:WLA - news) popular Lipitor cholesterol-lowering drug, itself a fast seller right out of the starting blocks, logged "only" 14,000 prescriptions during its third week, according to a report by health data tracker NDC Health Information Services. While the quick pace is definitely good news for Monsanto, the behind-the-scenes winner in this pharmacological version of the 100-meter dash may very well be Pfizer (NYSE:PFE - news). Since Pfizer is co-marketing both Celebrex and Lipitor, a fast start for both drugs translates into an equally quick expansion of the "Alliance Revenue" line of Pfizer's income statement in coming quarters. Pfizer also picked up $1 1/2 to $126 1/2 today.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next